Data / Research funding / Maryland
Maryland: 4,950 NIH awards ($12.1B) and 1,243 NSF awards ($649.5M) to 329 organizations
Organizations in Maryland hold 4,950 NIH awards ($12.1B) and 1,243 NSF awards ($649.5M) from NIH and NSF, across 329 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- MarylandState
Largest awards
The 300 largest of 6,193 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity | NIH | National Cancer Institute | 2021 to 2025 | $2,960,824,321 | August 31, 2025 | August 30, 2026 | BRISCOE, LYNN | reporter.nih.gov |
| NHLBI Community Engagement Technical Assistance Center (CETAC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $367,122,105 | September 25, 2020 | August 31, 2026 | BAYTOP, CHANZA | reporter.nih.gov |
| Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases: Mpox Clinical Research Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $150,331,625 | March 1, 2021 | February 28, 2026 | EWELL, MARIAN | reporter.nih.gov |
| BLDG. 538- 1ST FLOOR REFURBISHMENT AND INFRASTRUCTURE | NIH | National Cancer Institute | 2021 to 2025 | $116,680,370 | September 2, 2016 | June 30, 2019 | CRAIG, ROBILLARD | reporter.nih.gov |
| CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $86,933,457 | July 1, 2022 | June 30, 2026 | RAJU, SUDHIR | reporter.nih.gov |
| CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS) - SARS CoV-2 Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $86,825,316 | April 17, 2017 | April 16, 2024 | HOLMES, MELYNDA | reporter.nih.gov |
| Trans-Omics for Precision Medicine (TOPMed) Artificial Intelligence Coordinating Center (AI-CC) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $86,600,000 | September 25, 2024 | September 30, 2029 | MONTALVAN, REBECCA | reporter.nih.gov |
| INFORMATION TECHNOLOGY AND INFORMATICS SUPPORT TO THE DIVISION OF CANCER PREVENTION. | NIH | National Cancer Institute | 2021 to 2025 | $78,822,914 | September 22, 2022 | September 21, 2026 | RILEY, THOMAS | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| TASK ORDER 4A SITE STUDY SETUP: CTSU IDIQ | NIH | National Cancer Institute | 2022 to 2025 | $77,467,748 | August 1, 2022 | July 31, 2026 | PATRICHUK, LUCILLE | reporter.nih.gov |
| ECHO DAC (Environmental Influences on Child Health Outcomes Data Analysis Center) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $74,863,541 | September 21, 2016 | May 31, 2030 | JACOBSON, LISA P | reporter.nih.gov |
| The National Health and Aging Trends Study and National Study of Caregiving | NIH | National Institute on Aging | 2021 to 2025 | $65,386,641 | September 30, 2008 | March 31, 2029 | SCHRACK, JENNIFER ANN | reporter.nih.gov |
| COVID-19: NIAID Regulatory Support Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $63,227,516 | April 15, 2023 | April 14, 2024 | RAFI, ASIMAH | reporter.nih.gov |
| DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $51,529,857 | April 17, 2025 | April 16, 2026 | reporter.nih.gov | |
| DMID Clinical Research Operations & Management Support (CROMS): mpox activities | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $47,983,949 | April 1, 2024 | March 31, 2026 | ELLIS, JESSICA | reporter.nih.gov |
| Clinical Research Products Management Center (CRPMC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $46,852,833 | June 16, 2025 | June 15, 2026 | REMGSAMAI-NHE, CARINA | reporter.nih.gov |
| SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $45,166,816 | November 30, 2022 | November 29, 2025 | DRIVER, BARBARA | reporter.nih.gov |
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| STSS PROGRAM SUPPORT 5.0 | NIH | National Institute on Drug Abuse | 2023 to 2024 | $44,082,871 | November 27, 2023 | February 29, 2024 | MAYS, GARY | reporter.nih.gov |
| Regional Oncology Research Center | NIH | National Cancer Institute | 2021 to 2025 | $40,980,320 | May 7, 1997 | May 31, 2027 | NELSON, WILLIAM GEORGE | reporter.nih.gov |
| LC: HIV PREVENTION TRIALS NETWORK | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $40,489,166 | June 1, 2006 | November 30, 2027 | ESHLEMAN, SUSAN H | reporter.nih.gov |
| NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $40,099,690 | March 1, 2017 | February 29, 2024 | WOOD, ROBERT A | reporter.nih.gov |
| CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT-Moonshot Funding | NIH | National Cancer Institute | 2021 to 2025 | $38,115,589 | June 1, 2021 | May 31, 2026 | VALMONTE, CLAUDIA | reporter.nih.gov |
| CONTRACTOR: SOCIAL & SCIENTIFIC SYSTEMS, INC. TASK ORDER: 75N96021F00005 - IT INFRASTRUCTURE MAINTENANCE BASE PERIOD: JUNE 30, 2021 - JUNE 29, 2022 | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $38,110,184 | June 30, 2021 | June 29, 2026 | DELLA VALLE, MARK | reporter.nih.gov |
| Sister Study TASK ORDER 02: CHRONIC DISEASE VALIDATION & ANALYSES IN THE SISTER STUDY | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $37,573,166 | September 23, 2025 | July 22, 2030 | SANDLER, DALE | reporter.nih.gov |
| NeuroTech Harbor: Seedling Cohort 3 | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $35,143,434 | September 30, 2022 | June 30, 2027 | SARMA, SRIDEVI V. | reporter.nih.gov |
| Production of Aluminum Based Adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,078,534 | September 20, 2017 | December 31, 2026 | MACK, FRED | reporter.nih.gov |
| CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27. | NIH | National Institute on Drug Abuse | 2021 to 2025 | $33,434,913 | August 28, 2023 | August 27, 2026 | JELSTROM, EVE | reporter.nih.gov |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $32,243,461 | September 22, 2022 | October 9, 2029 | MEGAZZINI, KAREN | reporter.nih.gov |
| BIOMEDICAL COMPUTING SERVICES FOR NCI DCCPS | NIH | National Cancer Institute | 2021 to 2022 | $32,166,053 | July 3, 2020 | July 2, 2023 | RONEY, DAVID | reporter.nih.gov |
| IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP | NIH | National Cancer Institute | 2022 to 2025 | $31,120,905 | July 1, 2022 | June 30, 2026 | MILLER, LAUREN | reporter.nih.gov |
| Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $30,092,882 | August 16, 2021 | April 30, 2027 | PERSAUD, DEBORAH | reporter.nih.gov |
| Johns Hopkins Institute for Clinical and Translational Research | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $28,163,371 | May 31, 2019 | July 14, 2024 | FORD, DANIEL ERNEST | reporter.nih.gov |
| STSS: SMART IRB ONLINE RELIANCE SYSTEM (ORS) AND JOINDER ENHANCEMENTS SUPPORT SERVICES | NIH | National Institute on Drug Abuse | 2021 to 2022 | $27,880,093 | April 15, 2022 | April 14, 2023 | MAYS, GARY | reporter.nih.gov |
| Services to Operate the National Oral Health Information Center (NOHIC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $26,625,993 | October 16, 2024 | October 15, 2025 | reporter.nih.gov | |
| New Horizons in the Prevention and Treatment of Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $25,961,502 | April 4, 2024 | February 28, 2031 | WOOD, ROBERT A | reporter.nih.gov |
| DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25). | NIH | National Institute on Drug Abuse | 2022 to 2025 | $25,789,598 | March 1, 2025 | February 28, 2026 | reporter.nih.gov | |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| The Johns Hopkins Center for AIDS Research (JHU CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,770,118 | May 2, 2012 | April 30, 2027 | CHAISSON, RICHARD E. | reporter.nih.gov |
| The Mid-Atlantic Center for Cardiometabolic Health (MACCH) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,163,298 | September 24, 2021 | June 30, 2027 | COOPER, LISA A | reporter.nih.gov |
| TASK ORDER 7R - CLINICAL MONITORING ACTIVITIES | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $24,157,736 | July 1, 2021 | June 30, 2025 | KOHRMAN, OLIVIA | reporter.nih.gov |
| TO PROVIDE SEQUENCING SERVICES USING WHOLE GENOME SEQUENCING (GERMLINE FFPE) FOR NCI (KLEIN) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $24,069,896 | September 27, 2023 | December 31, 2025 | DOHENY, KIM | reporter.nih.gov |
| TASK ORDER 7 - ODP | NIH | National Institute on Drug Abuse | 2024 | $23,970,498 | May 31, 2024 | September 30, 2024 | MAYS, GARY | reporter.nih.gov |
| Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $23,837,604 | April 9, 2019 | September 30, 2026 | GANGE, STEPHEN J | reporter.nih.gov |
| NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $23,280,590 | August 1, 2021 | January 14, 2027 | PEKOSZ, ANDREW | reporter.nih.gov |
| Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $23,170,962 | September 21, 2022 | September 20, 2026 | SCHROCK, RICHARD | reporter.nih.gov |
| CTSU CORE SUPPORT SERVICES AND THE CTSU ENTERPRISE OF SYSTEMS - TASK AREA II | NIH | National Cancer Institute | 2021 | $22,304,622 | August 31, 2020 | August 30, 2021 | MARTIER, KAREN | reporter.nih.gov |
| THE SCOPE OF THIS PROCUREMENT IS TO DEVELOP, REFINE, DEPLOY, VALIDATE, MAINTAIN, AND SUPPORT A NEXT-GENERATION CLOUD-BASED ELECTRONIC VISION-RELATED QUALITY OF LIFE EPRO PLATFORM FOR USE BY NIH AND IT | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $21,721,781 | September 29, 2025 | September 28, 2026 | STARK, KAREN A. | reporter.nih.gov |
| Utilizing Technology and AI Approaches to Facilitate Independence and Resilience in Older Adults | NIH | National Institute on Aging | 2021 to 2025 | $21,409,187 | September 30, 2021 | May 31, 2027 | CHELLAPPA, RAMA | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2021 to 2023 | $21,394,060 | September 1, 2019 | August 31, 2024 | VALMONTE, CLAUDINE | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| NIAID Specimen Repository | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,383,408 | September 30, 2025 | September 29, 2026 | PHIPPARD, DEBORAH | reporter.nih.gov |
| SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $19,936,404 | August 25, 2025 | August 24, 2026 | DRIVER, BARBARA | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,720,676 | September 16, 2019 | September 15, 2026 | FRANKENFIELD, JILL | reporter.nih.gov |
| North American AIDS Cohorts on Collaboration and Design (NAACCORD) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,377,019 | July 1, 2006 | April 30, 2027 | ALTHOFF, KERI NICOLE | reporter.nih.gov |
| Johns Hopkins Institute for Clinical and Translational Research | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $19,350,081 | May 15, 2024 | April 30, 2031 | FORD, DANIEL ERNEST | reporter.nih.gov |
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| NCATS CLINICAL AND TRANSLATIONAL SCIENCE AWARDS (CTSA) PROGRAM: COORDINATION, COMMUNICATION AND OPERATIONS SUPPORT (CCOS) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $18,278,076 | September 23, 2022 | July 31, 2025 | BOUR, STEPHAN | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2023 to 2025 | $18,271,500 | February 1, 2023 | January 31, 2026 | MAHZAD, MEHRINFAR | reporter.nih.gov |
| Hazardous Materials Worker Health and Safety Training | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $18,262,704 | September 21, 1992 | May 31, 2030 | CAIN, CHRISTINA TRAHAN | reporter.nih.gov |
| Institute for Trustworthy AI in Law and Society (TRAILS) | NSF | Center Scale & Testbeds | 2023 | $18,190,049 | June 1, 2023 | May 31, 2028 | Hal Daumé | nsf.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2024 to 2025 | $18,014,450 | September 1, 2024 | August 31, 2026 | VALMONTE, CLAUDINE | reporter.nih.gov |
| RCMI@Morgan: Center for Urban Health Disparities Research and Innovation | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $17,823,120 | July 31, 2019 | June 30, 2029 | TCHOUNWOU, PAUL B. | reporter.nih.gov |
| Johns Hopkins Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,187,390 | April 15, 2020 | March 31, 2030 | ALBERT, MARILYN S. | reporter.nih.gov |
| Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort | NIH | National Institute on Aging | 2021 to 2025 | $16,952,609 | July 1, 2009 | May 31, 2027 | ALBERT, MARILYN S. | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) ADMINISTRATIVE COORDINATING CENTER (ACC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $16,650,520 | August 23, 2021 | August 22, 2026 | SHIFFLETT, PATRICIA | reporter.nih.gov |
| Cognition & Hippocampal/Cortical Systems in Aging | NIH | National Institute on Aging | 2021 to 2025 | $16,383,227 | September 1, 1997 | March 31, 2027 | KNIERIM, JAMES J | reporter.nih.gov |
| A quality control pipeline for enhancing reproducibility of immunology studies with shared data | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,036,849 | July 12, 2021 | April 30, 2027 | PASETTI, MARCELA F | reporter.nih.gov |
| Advancement of Vaccines and Therapies for Henipaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $16,013,774 | March 20, 2019 | February 28, 2026 | BRODER, CHRISTOPHER C | reporter.nih.gov |
| Patient Safety Monitoring in International Laboratories (SMILE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,856,301 | November 15, 2024 | November 14, 2025 | SOKOLL, LORI | reporter.nih.gov |
| ARIC Neurocognitive Study (ARIC-NCS) Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,682,941 | July 7, 2010 | March 31, 2024 | CORESH, JOSEF | reporter.nih.gov |
| NIAID Influenza Data Processing and Communication Center: Universal Influenza Vaccine Research Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,386,477 | April 1, 2021 | March 31, 2026 | BOUR, STEPHAN | reporter.nih.gov |
| Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,223,601 | September 1, 2021 | May 31, 2027 | MILTON, DONALD KIRBY | reporter.nih.gov |
| NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa | NIH | National Eye Institute | 2022 to 2025 | $15,187,946 | March 17, 2022 | July 31, 2027 | KONG, XIANGRONG | reporter.nih.gov |
| Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science | NIH | National Institute on Drug Abuse | 2021 to 2025 | $14,801,288 | September 30, 2018 | August 31, 2028 | STANTON, CASSANDRA A | reporter.nih.gov |
| Child Neurologist Career Development Program | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $14,787,372 | August 15, 2016 | July 31, 2027 | SCHLAGGAR, BRADLEY L | reporter.nih.gov |
| Johns Hopkins University Trial Innovation Center | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $14,762,337 | July 5, 2023 | April 30, 2028 | HANLEY, DANIEL F | reporter.nih.gov |
| Neighborhoods, Stress and Cancer Outcomes Across the Cancer Control Continuum: Leveraging ecological theory and geospatial analytics to improve cancer prevention and outcomes (Project LEGO) | NIH | National Cancer Institute | 2021 to 2025 | $14,533,475 | August 8, 2008 | August 31, 2027 | OWONIKOKO, TAOFEEK K | reporter.nih.gov |
| Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,366,354 | May 1, 2021 | December 31, 2026 | COX, ANDREA L | reporter.nih.gov |
| Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study | NIH | National Institute on Aging | 2022 to 2025 | $14,339,100 | August 15, 2022 | July 31, 2028 | DEAL, JENNIFER ANNE | reporter.nih.gov |
| NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 03/01/2022 - 02/28/2023. N01DA-19-2250. TASK ORDER 75N95022F00001 (TO | NIH | National Institute on Drug Abuse | 2021 to 2022 | $14,328,957 | March 1, 2022 | February 28, 2023 | MCCORMACK, JENNIFER | reporter.nih.gov |
| Regulatory Affairs Support | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $14,297,275 | July 1, 2022 | June 30, 2026 | HEREDIA, ELIZABETH | reporter.nih.gov |
| HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed) | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $13,629,736 | September 21, 1992 | July 31, 2030 | CAIN, CHRISTINA TRAHAN | reporter.nih.gov |
| Expanding the AnVIL (Analysis, Visualization, and Informatics Lab-space) | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,613,143 | September 21, 2018 | April 30, 2028 | SCHATZ, MICHAEL | reporter.nih.gov |
| Graduate Research Fellowship Program (GRFP) | NSF | Scholarships, Fellowships, and Traineeships Section | 2022 | $13,387,955 | September 1, 2022 | August 31, 2027 | Stephen M Roth | nsf.gov |
| REDS-IV-P DATA COORDINATING CENTER (DCC) PHASE 3 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,265,216 | April 1, 2024 | June 30, 2026 | CHAPMAN, KATHY | reporter.nih.gov |
| TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | NIH | National Institute on Drug Abuse | 2024 to 2025 | $13,234,516 | July 16, 2025 | July 15, 2026 | reporter.nih.gov | |
| IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody | NIH | National Institute on Drug Abuse | 2023 to 2025 | $13,125,765 | May 1, 2023 | April 30, 2027 | KALNIK, MATTHEW W | reporter.nih.gov |
| RADXHIV VIRAL LOAD | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $12,723,739 | September 11, 2007 | July 31, 2028 | MANABE, YUKARI C | reporter.nih.gov |
| THE NIH NEUROBIOBANK AND TISSUE REPOSITORY | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,702,242 | May 1, 2025 | October 31, 2025 | BLANCHARD, THOMAS | reporter.nih.gov |
| Transforming Human Pancreatic Cancer Into An Immunologic Disease | NIH | National Cancer Institute | 2021 to 2025 | $12,679,276 | June 1, 2021 | May 31, 2027 | JAFFEE, ELIZABETH M. | reporter.nih.gov |
| AIDS Linked to the IntraVenous Experience (ALIVE) Study | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,226,379 | January 1, 2014 | May 31, 2030 | MEHTA, SHRUTI H | reporter.nih.gov |
| Phase III double-blind, randomized controlled trial of suvorexant versus placebo to treat insomnia in persons with opioid use disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $12,205,195 | May 15, 2024 | February 28, 2027 | HUHN, ANDREW S | reporter.nih.gov |
| NATIONAL CLINICAL DATA COLLABORATIVE COUNTS (NACDACC) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $12,127,951 | September 30, 2024 | September 29, 2025 | MAYS, GARY | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | NIH | National Institute on Drug Abuse | 2022 to 2025 | $11,758,351 | March 11, 2024 | April 29, 2027 | MAYER, CHRISTINA | reporter.nih.gov |
| THE PURPOSE OF THIS TASK ORDER IS TO MAINTAIN AND ENHANCE THE NIDDK BIOREPOSITORY ROUTINE OPERATIONS TO FACILITATE BIOSPECIMEN UTILIZATION FOR NEW SCIENCE AND BROAD SHARING ACROSS THE RESEARCH COMMUNI | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $11,532,454 | May 30, 2025 | May 29, 2026 | LANGENBACH, KURT | reporter.nih.gov |
| Reagent Resource Support Program for AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,522,629 | April 8, 2018 | April 7, 2025 | FREMONT, VALERIE | reporter.nih.gov |
| The Johns Hopkins University-Blantyre Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,246,510 | February 15, 2007 | November 30, 2027 | TAHA, TAHA E | reporter.nih.gov |
| DATA COORDINATING CENTER TO PROVIDE SERVICES TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM CLINICAL SITES TO PROVIDE MANAGEMENT AND DATABASE CAPABILITIES, SCIENTIFIC EXPERTISE, | NIH | National Institute on Drug Abuse | 2023 to 2025 | $11,232,511 | August 7, 2025 | August 6, 2026 | SHERMAN, SETH | reporter.nih.gov |
| Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,947,708 | February 5, 2007 | November 30, 2027 | GUPTA, AMITA | reporter.nih.gov |
| STORAGE OF NUMOM2B SPECIMENS FOR THE PREGNANCY AND PERINATOLOGY BRANCH OF NICHD | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $10,932,821 | September 27, 2018 | September 26, 2025 | MANDACI, OGUZ | reporter.nih.gov |
| Data Center for Acute to Chronic Pain Biosignatures | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,727,611 | September 1, 2019 | July 31, 2027 | LINDQUIST, MARTIN | reporter.nih.gov |
| Pathogenesis of E. coli and Shigella infections in human enteroid models | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,668,620 | July 1, 2016 | June 30, 2027 | KAPER, JAMES B | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2021 to 2022 | $10,577,768 | February 1, 2018 | January 31, 2023 | MEHRINFAR, MAHZAD | reporter.nih.gov |
| NIDDK BIOSAMPLE AND GENETICS REPOSITORY CONTRACT. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $10,513,118 | September 28, 2016 | May 29, 2023 | EDUARD, CHANI | reporter.nih.gov |
| A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $10,487,739 | September 25, 2019 | August 31, 2025 | CAMPBELL, CLAUDIA MICHELLE | reporter.nih.gov |
| Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,457,548 | June 16, 2020 | May 31, 2026 | CARRIER, FRANCE | reporter.nih.gov |
| HIGH THROUGHPUT GENOTYPING AND DNA SEQUENCING FOR STUDYING THE GENETIC CONTRIBUTIONS TO HUMAN HEALTH AND DISEASE | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $10,443,705 | September 26, 2025 | September 25, 2028 | reporter.nih.gov | |
| A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $10,352,397 | April 15, 2014 | March 31, 2025 | RASKO, DAVID A | reporter.nih.gov |
| Establish a Public Private Partnership for COVID19 Research | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $10,186,691 | May 2, 2020 | February 29, 2024 | ADAM, STACEY | reporter.nih.gov |
| EPIDEMIOLOGY SUPPORT TASK ORDER - BASE YEAR PERIOD OF PERFORMANCE, APRIL 17, 2023 - APRIL 16, 2024 AND FOUR OPTIONAL PERIODS. PROFESSIONAL SERVICES | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $10,008,731 | April 17, 2025 | April 16, 2026 | BYRD-CLARK, DANITA | reporter.nih.gov |
| Neuropixels NXT: Integrated Silicon Probes for Large Scale Extracellular Recording in Rodents and Primates | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $10,002,432 | September 1, 2020 | May 31, 2025 | HARRIS, TIMOTHY D | reporter.nih.gov |
| The Military HIV Research Program (MHRP) Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,676 | December 10, 2013 | November 30, 2027 | ROBB, MERLIN L | reporter.nih.gov |
| The Johns Hopkins University - Uganda Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,249 | February 5, 2007 | November 30, 2027 | FOWLER, MARY GLENN | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| TASK ORDER 1 - OCR PROJECT MANAGEMENT, DSMB AND CROMS-RELATED SUPPORT | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,613,167 | March 25, 2024 | March 24, 2026 | APPELMANS, ELINE | reporter.nih.gov |
| Medical Scientist Training Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $9,598,978 | July 1, 2020 | June 30, 2030 | COX, ANDREA L | reporter.nih.gov |
| Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $9,584,357 | September 30, 2025 | September 29, 2026 | SILVERA, PETER | reporter.nih.gov |
| Task B1: Phase I Clinical Trial to Evaluate a Therapeutic for Antibiotic Resistant Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,576,633 | May 13, 2021 | January 31, 2025 | BURMAN, BRIDGETT | reporter.nih.gov |
| POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY PERIOD OF PERFORMANCE: 02/01/2024 - 11/30/2030. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,560,337 | February 1, 2024 | November 30, 2029 | CARUSI, CHARLES | reporter.nih.gov |
| BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial | NIH | National Institute on Aging | 2021 to 2025 | $9,481,336 | February 15, 2021 | November 30, 2026 | HANLEY, DANIEL F | reporter.nih.gov |
| 2/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT UMB | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,449,174 | September 30, 2015 | March 31, 2027 | ERNST, THOMAS M | reporter.nih.gov |
| SPORE in Cervical Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,421,122 | September 30, 2003 | August 31, 2029 | WU, TZYY-CHOOU | reporter.nih.gov |
| Network of the National Library of Medicine Region 1 | NIH | National Library of Medicine | 2021 to 2025 | $9,395,823 | May 1, 2021 | April 30, 2027 | HURST, EMILY | reporter.nih.gov |
| Environmental Approaches to Prevention | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $9,318,439 | September 29, 1983 | November 30, 2027 | PASCHALL, MALLIE J | reporter.nih.gov |
| Skeleton and Joint Degeneration with Aging | NIH | National Institute on Aging | 2021 to 2025 | $9,233,589 | January 15, 2021 | December 31, 2026 | CAO, XU | reporter.nih.gov |
| University of Maryland NIH Data Commons Facilitation Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $9,122,579 | September 30, 2017 | April 30, 2024 | WHITE, OWEN R | reporter.nih.gov |
| GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $9,120,320 | September 6, 2022 | August 31, 2027 | VOLK, HEATHER E | reporter.nih.gov |
| 7/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,118,437 | September 30, 2021 | June 30, 2026 | VOLK, HEATHER E | reporter.nih.gov |
| University of Maryland FIRST Program | NIH | National Cancer Institute | 2022 to 2024 | $8,886,100 | September 9, 2022 | August 31, 2027 | KAPER, JAMES B | reporter.nih.gov |
| Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN Supplement | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,842,412 | July 1, 2016 | June 30, 2023 | HANLEY, DANIEL F | reporter.nih.gov |
| SPORE in Ovarian Cancer | NIH | National Cancer Institute | 2021 to 2025 | $8,793,516 | September 18, 2018 | July 31, 2029 | SHIH, IE-MING | reporter.nih.gov |
| Development of Therapeutic Candidates for Biodefense, Infections and Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $8,743,439 | September 25, 2023 | June 24, 2024 | RAMSTEDT, URBAN | reporter.nih.gov |
| Tools for gene editing in marmosets | NIH | National Institute on Drug Abuse | 2022 to 2025 | $8,672,011 | September 1, 2022 | June 30, 2027 | WANG, XIAOQIN | reporter.nih.gov |
| Data Coordinating Center for the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Continuation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,663,508 | May 1, 2002 | June 30, 2028 | SHADE, DAVID M | reporter.nih.gov |
| NCATS SCIENTIFIC AND TECHNOLOGY SUPPORT SERVICES (STSS) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $8,491,687 | September 30, 2024 | January 6, 2025 | MAYS, GARY | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,478,988 | April 1, 2020 | March 31, 2027 | LEWIS, MARK | reporter.nih.gov |
| Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,382,660 | February 1, 2019 | May 31, 2029 | CAMERON, ANDREW M. | reporter.nih.gov |
| Kynurenic Acid and Cognitive Abnormalities in Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2023 | $8,381,869 | May 9, 2014 | June 30, 2025 | SCHWARCZ, ROBERT | reporter.nih.gov |
| Creation of a Trusted Data Broker, Development of a Data Access Platform and Design of a Public Private Partnership to Implement the NIH's Data COUNTS Program for Access to Quality Data. | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $8,349,817 | September 25, 2024 | September 24, 2026 | ADAM, STACEY | reporter.nih.gov |
| A BRAIN Initiative Resource: The Neuroscience Multi-omic Data Archive | NIH | National Institute of Mental Health | 2021 to 2025 | $8,199,148 | September 15, 2017 | June 30, 2027 | WHITE, OWEN R | reporter.nih.gov |
| CCDI SUPPORT FOR NIH/NCI/DCCPS SURVEILLANCE RESEARCH PROGRAM | NIH | National Cancer Institute | 2021 to 2025 | $8,176,428 | August 16, 2021 | August 15, 2026 | reporter.nih.gov | |
| CLINICAL STUDIES MANAGEMENT AND SUPPORT (CSMS) - SOLE SOURCE BRIDGE CONTRACT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,078,483 | September 30, 2021 | January 24, 2025 | YOU, HUIQING | reporter.nih.gov |
| Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $8,076,617 | July 15, 2022 | July 14, 2023 | SILVERA, PETER | reporter.nih.gov |
| Center for Innovative Research, Capacity Building and Leadership Development to End Substance Use Harms (CIRCLE) | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,002,205 | September 1, 2023 | June 30, 2028 | WALLS, MELISSA L. | reporter.nih.gov |
| Task C16: Production and Development of Schistosomiasis Research Reagents | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,933,000 | February 1, 2023 | January 31, 2026 | MENTINK-KANE, MARGARET | reporter.nih.gov |
| NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $7,818,967 | September 15, 2021 | September 14, 2022 | MOLINA, DANIEL | reporter.nih.gov |
| Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,818,042 | February 2, 2021 | January 31, 2027 | CHANG, LARRY WILLIAM | reporter.nih.gov |
| 16/24 Healthy Brain and Child Development National Consortium | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,814,498 | September 30, 2021 | June 30, 2026 | FOX, NATHAN A | reporter.nih.gov |
| NCATS SCIENTIFIC AND TECHNOLOGY PROGRAM SUPPORT (STPS) | NIH | National Institute on Drug Abuse | 2025 | $7,700,000 | February 18, 2025 | September 27, 2025 | reporter.nih.gov | |
| Structure, immunity and microbiome: Human 3D biomimetics cervicovaginal models for sexually transmitted infections (SIM-STI) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,671,044 | April 20, 2021 | March 31, 2027 | RAVEL, JACQUES | reporter.nih.gov |
| Online Mendelian Inheritance in Man (OMIM) | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,662,601 | June 15, 2012 | March 31, 2028 | HAMOSH, ADA | reporter.nih.gov |
| Imaging, Dosimetry and Radiobiology for α-particle Emitter Radiopharmaceutical Therapy | NIH | National Cancer Institute | 2023 to 2025 | $7,643,369 | September 19, 2023 | August 31, 2028 | KIESS, ANA PONCE | reporter.nih.gov |
| Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatment | NIH | National Institute on Drug Abuse | 2021 to 2023 | $7,640,612 | May 1, 2023 | April 30, 2026 | GORDON, MICHAEL SCOTT | reporter.nih.gov |
| DRUG DEVELOPMENT SUPPORT FOR THE CANCER THERAPY EVALUATION PROGRAM (CTEP) | NIH | National Cancer Institute | 2021 | $7,562,000 | July 1, 2015 | June 30, 2022 | SAUNDERS, JOAN | reporter.nih.gov |
| REpeated ASseSsmEnt of SurvivorS in ICH (REASSESS ICH) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $7,516,765 | January 1, 2022 | December 31, 2027 | ZIAI, WENDY C | reporter.nih.gov |
| Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $7,500,000 | March 15, 2019 | February 28, 2025 | LEVINE, MYRON MAX | reporter.nih.gov |
| QLCI: Institute for Robust Quantum Simulation (RQS) | NSF | MPS - Core Programs | 2026 | $7,500,000 | September 1, 2026 | August 31, 2031 | Mohammad Hafezi | nsf.gov |
| Collaborative Influenza Vaccine Innovation Centers STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,400,390 | September 30, 2025 | September 29, 2026 | BOUR, STEPHAN | reporter.nih.gov |
| JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) | NIH | National Institute of Mental Health | 2021 to 2025 | $7,358,007 | June 16, 2006 | February 28, 2027 | RUBIN, LEAH HELANE | reporter.nih.gov |
| IGF::OT::IGFEMMES NEIS-V | NIH | Office of the Director, National Institutes of Health | 2021 | $7,315,897 | November 1, 2016 | October 31, 2021 | HAMMEL, KERI | reporter.nih.gov |
| IGF::OT::IGF TASK AREA A - MAINTAINING AND ENHANCING THE BIOLINCC PROGRAM | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,272,737 | November 16, 2023 | November 15, 2025 | GIFFEN, CAROL | reporter.nih.gov |
| SUPPORT THE ONGOING OPERATIONS OF THE NATIONAL DATABASE FOR AUTISM RESEARCH - NDAR | NIH | National Institute on Drug Abuse | 2021 | $7,242,156 | January 1, 2021 | March 31, 2021 | GOODWIN, JOHN | reporter.nih.gov |
| REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT | NIH | National Cancer Institute | 2023 to 2025 | $7,231,030 | March 1, 2024 | February 28, 2025 | SCHROCK, RICHARD | reporter.nih.gov |
| Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $7,209,820 | September 23, 2022 | August 31, 2027 | HANLEY, DANIEL F | reporter.nih.gov |
| Escitalopram for Agitation in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2022 | $7,145,681 | September 30, 2016 | May 31, 2024 | LYKETSOS, CONSTANTINE G | reporter.nih.gov |
| Adjuvant Development of the TLR4 Ligand BECC470s For Use in Influenza, S. aureus, and P. aeruginosa Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,143,498 | September 30, 2023 | September 29, 2028 | SORENSON, GREGORY | reporter.nih.gov |
| NeMO Archive: SCORCH Support, Coordination and Outreach | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,111,105 | August 1, 2020 | June 30, 2030 | WHITE, OWEN R | reporter.nih.gov |
| NINDS CENTER FOR CLINICAL TRIAL RESOURCES | NIH | National Institute on Drug Abuse | 2022 to 2025 | $7,088,164 | September 30, 2022 | September 29, 2026 | HEFNER, KATHRYN | reporter.nih.gov |
| Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $7,057,359 | September 10, 2021 | August 31, 2027 | MCCAUL, MARY E | reporter.nih.gov |
| Enhanced Cohort methods for HIV Research and Epidemiology (ENCORE) in the United States | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,056,913 | August 9, 2022 | December 31, 2027 | COONEY, ERIN EILEEN | reporter.nih.gov |
| Sickle Cell Disease Cure Initiative (SCDC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,000,926 | September 30, 2017 | June 30, 2026 | COLEMAN-COWGER, VICTORIA HOPE | reporter.nih.gov |
| Accelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $6,977,446 | August 1, 2025 | June 30, 2030 | CASADEVALL, ARTURO | reporter.nih.gov |
| University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC) | NIH | National Institute on Aging | 2021 to 2025 | $6,970,364 | September 15, 2006 | June 30, 2027 | RYAN, ALICE S. | reporter.nih.gov |
| N3C DYNAMIC WORKSPACES FOR NCATS | NIH | National Institute on Drug Abuse | 2025 | $6,863,767 | September 30, 2025 | March 30, 2026 | reporter.nih.gov | |
| U-RISE at University of Maryland Baltimore County | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $6,821,602 | April 1, 2020 | March 31, 2030 | ROBINSON, PHYLLIS R | reporter.nih.gov |
| Center for 3D Imaging in Cancer Cell Biology | NIH | National Cancer Institute | 2022 to 2025 | $6,786,746 | December 1, 2021 | November 30, 2026 | WIRTZ, DENIS | reporter.nih.gov |
| Older Americans Independence Center | NIH | National Institute on Aging | 2021 to 2025 | $6,766,168 | June 1, 2003 | June 30, 2028 | BANDEEN-ROCHE, KAREN J. | reporter.nih.gov |
| The Kidney Disease in Children Data Management and Analysis Center (KIDMAC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,688,610 | September 30, 2003 | July 31, 2028 | NG, DEREK K | reporter.nih.gov |
| Bone Marrow Transplantation in Human Disease | NIH | National Cancer Institute | 2021 to 2024 | $6,665,085 | May 21, 2019 | April 30, 2026 | JONES, RICHARD J | reporter.nih.gov |
| Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,605,926 | December 9, 2021 | November 30, 2026 | LENG, SEAN XIAO | reporter.nih.gov |
| BIOLOGICAL SPECIMENS' RECEIPT, STORAGE, MANAGEMENT AND DISTRIBUTION | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,564,413 | July 30, 2023 | July 29, 2025 | LANGENBACH, KURT | reporter.nih.gov |
| Impact of the olfactory system on higher brain function and schizophrenia | NIH | National Institute of Mental Health | 2024 to 2025 | $6,562,046 | April 15, 2024 | January 31, 2029 | SAWA, AKIRA | reporter.nih.gov |
| Center to Accelerate Translation of Interventions to Decrease Premature Mortality in Persons with Serious Mental Illness | NIH | National Institute of Mental Health | 2021 to 2025 | $6,505,602 | August 15, 2018 | April 30, 2029 | DAUMIT, GAIL L. | reporter.nih.gov |
| MRI Resource for Physiologic, Metabolic and Anatomic Biomarkers | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,467,103 | July 1, 2021 | June 30, 2026 | VAN ZIJL, PETER CM | reporter.nih.gov |
| The Gonorrhea Vaccine Cooperative Research Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,384,930 | March 26, 2019 | February 28, 2025 | JERSE, ANN E. | reporter.nih.gov |
| Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS) | NIH | National Cancer Institute | 2022 to 2024 | $6,357,502 | September 30, 2020 | August 31, 2025 | KLEIN, SABRA L. | reporter.nih.gov |
| Understanding reservoir dynamics through analysis of viral decay processes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,324,187 | April 1, 2022 | March 31, 2027 | SILICIANO, ROBERT F | reporter.nih.gov |
| Intellectual and Developmental Disabilities Research Centers | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $6,315,261 | April 1, 2025 | May 31, 2026 | SCHLAGGAR, BRADLEY L | reporter.nih.gov |
| Division of Microbiology and Infectious Diseases (DMID) Clinical Materials Services | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,289,517 | September 22, 2017 | September 21, 2021 | KUDRICK, JOHN | reporter.nih.gov |
| DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $6,287,950 | September 15, 2015 | July 14, 2023 | NORDSTROM, JEFFREY | reporter.nih.gov |
| NEWBORN SCREENING TRANSLATIONAL RESEARCH NETWORK (NBSTRN). | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $6,244,067 | September 26, 2018 | March 25, 2024 | BROWER, AMY | reporter.nih.gov |
| The Johns Hopkins Translational ImmunoEngineering (JH-TIE) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,232,538 | September 15, 2019 | April 30, 2029 | SCHNECK, JONATHAN P | reporter.nih.gov |
| TASK ORDER 75N92022F00001 (TASK ORDER 8) FOR TASK AREA A, B, C & D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,220,963 | March 31, 2022 | March 31, 2024 | LANGENBACH, KURT | reporter.nih.gov |
| 1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $6,197,105 | September 26, 2019 | August 31, 2025 | BAKER, VALERIE LYNN | reporter.nih.gov |
| Center: NSF Engineering Research Center for Quantum Networks | NSF | Engineering Education Centers | 2026 | $6,135,001 | September 1, 2026 | August 31, 2031 | Saikat Guha | nsf.gov |
| S4 TO 108 NCATS GENE THERAPY VECTOR | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $6,133,050 | September 30, 2021 | September 29, 2024 | KOROLEVA, ANNA | reporter.nih.gov |
| Development of a Longitudinal Observational Research Registry for the Study of Medicinal Cannabis Use and Health | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,116,522 | June 1, 2023 | April 30, 2028 | VANDREY, RYAN G | reporter.nih.gov |
| Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $6,082,974 | September 15, 2022 | August 31, 2027 | DE MARZO, ANGELO MICHAEL | reporter.nih.gov |
| PGpR2 Year 3 Supplement for the Scientific Data Research Center (SDRC) of the GpCRC 4 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,054,841 | May 1, 2006 | July 31, 2027 | SHADE, DAVID M | reporter.nih.gov |
| 2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,043,000 | August 25, 2022 | July 31, 2029 | HANLEY, DANIEL F | reporter.nih.gov |
| The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies | NIH | National Cancer Institute | 2021 to 2025 | $6,006,072 | March 13, 2014 | February 28, 2027 | CARDUCCI, MICHAEL A | reporter.nih.gov |
| Johns Hopkins HIV Clinical Cohort | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,955,256 | July 1, 2014 | March 31, 2026 | MOORE, RICHARD DOUGLAS | reporter.nih.gov |
| Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center | NIH | National Cancer Institute | 2022 to 2025 | $5,942,158 | August 4, 2022 | July 31, 2027 | SAWANT, AMIT | reporter.nih.gov |
| Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,933,702 | April 8, 2021 | March 31, 2027 | SIM, B. KIM LEE | reporter.nih.gov |
| THE PURPOSE OF THIS TASK ORDER IS TO PROVIDE THE NATIONAL INSTITUTE ON AGING WITH INFORMATION RESOURCE CENTER SERVICES IN ACCORDANCE WITH THE ATTACHED STATEMENT OF WORK AND QUOTE DATED 8/1/2025. | NIH | National Institute on Drug Abuse | 2024 to 2025 | $5,908,784 | September 16, 2025 | September 15, 2026 | reporter.nih.gov | |
| Bicoastal Marmoset Breeding Center | NIH | National Institute of Mental Health | 2021 to 2025 | $5,837,279 | July 15, 2020 | May 31, 2030 | WANG, XIAOQIN | reporter.nih.gov |
| Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,833,457 | August 15, 2024 | May 31, 2031 | PUTCHA, NIRUPAMA | reporter.nih.gov |
| MAINTENANCE OF THE NHLBI BIOLOGIC SPECIMEN REPOSITORYTASK AREA B AND TASK AREA C | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,830,617 | April 21, 2025 | March 31, 2026 | MARSHALL, SCOTT L | reporter.nih.gov |
| Multidisciplinary Training Program in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,823,861 | July 1, 1982 | June 30, 2028 | SHIMODA, LARISSA A. | reporter.nih.gov |
| NSF INCLUDES Alliance: Re-Imagining STEM Equity Utilizing Postdoctoral Pathways | NSF | Div. of Equity for Excellence in STEM | 2022 | $5,794,026 | August 15, 2022 | May 2, 2025 | Manfred H van Dulmen | nsf.gov |
| Early Psychosis Intervention Network (EPINET): Data Coordinating Center | NIH | National Institute of Mental Health | 2021 to 2023 | $5,780,626 | September 10, 2019 | June 30, 2025 | ROSENBLATT, ABRAM | reporter.nih.gov |
| Harnessing Innovation to Transform Malaria Surveillance into Key Interventions Across Transmission Settings in Zambia | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,763,780 | July 1, 2010 | March 31, 2029 | MOSS, WILLIAM J | reporter.nih.gov |
| Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,744,264 | June 1, 2016 | April 30, 2025 | LAI, SHENGHAN | reporter.nih.gov |
| Rational design and efficacy testing of vaccines against HCV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,737,237 | May 5, 2022 | April 30, 2027 | FUERST, THOMAS R | reporter.nih.gov |
| Excitable Networks in Directed Cell Migration | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,736,964 | May 1, 2016 | April 30, 2026 | DEVREOTES, PETER N | reporter.nih.gov |
| Cross-Species Analyses of the Molecular and Circuit Basis ofSleep | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,714,123 | May 1, 2021 | April 30, 2029 | WU, MARK N | reporter.nih.gov |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,708,012 | May 5, 2022 | June 30, 2029 | MINKOVITZ, CYNTHIA S | reporter.nih.gov |
| Computational Methods for Gene Discovery, Genome Annotation, and Genome Assembly | NIH | National Human Genome Research Institute | 2021 to 2025 | $5,706,493 | September 1, 1999 | August 31, 2029 | SALZBERG, STEVEN L. | reporter.nih.gov |
| Collaborative Research: Implementation Grant: Active Societal Participation In Research and Education | NSF | GEO - Core Programs | 2024 | $5,672,851 | April 15, 2024 | March 31, 2029 | Lora A Harris | nsf.gov |
| Earlier-Life Predictors of Midlife Risk Factors for Dementia: A 35-Year Follow-up (Revision) | NIH | National Institute on Aging | 2023 to 2025 | $5,646,724 | March 1, 2023 | February 29, 2028 | REBOK, GEORGE W. | reporter.nih.gov |
| SCIENTIFIC SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE, DIVISION OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS), CALL ORDER 3 UNDER BPA #HHSN261201800002B | NIH | National Cancer Institute | 2023 to 2024 | $5,606,948 | July 27, 2023 | July 26, 2025 | WOODY, TORRISE | reporter.nih.gov |
| Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,552,808 | April 1, 2022 | March 31, 2027 | LIMA, JOAO A C | reporter.nih.gov |
| Hepatitis B and HIV Cure Consortium (BICC) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $5,504,270 | September 26, 2025 | July 31, 2030 | THIO, CHLOE L | reporter.nih.gov |
| Expansion and modification of animal housing and support spaces to increase production of the NIH U42 supported pigtailed macaque colony at Johns Hopkins University | NIH | Office of the Director, National Institutes of Health | 2022 | $5,500,152 | September 20, 2022 | May 31, 2027 | MANKOWSKI, JOSEPH L | reporter.nih.gov |
| Proteogenomic Characterization of Tumor Tissues and Preclinical Models with High Precision | NIH | National Cancer Institute | 2022 to 2025 | $5,481,323 | June 1, 2022 | May 31, 2027 | ZHANG, HUI | reporter.nih.gov |
| JHU-Mayo-NIA Murine Senescence Mapping Program (JMN-MSMP) | NIH | National Institute on Aging | 2022 to 2025 | $5,465,667 | August 1, 2022 | July 31, 2027 | ELISSEEFF, JENNIFER H | reporter.nih.gov |
| REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT | NIH | National Cancer Institute | 2021 to 2024 | $5,446,831 | March 1, 2016 | February 27, 2021 | LEE, MARK | reporter.nih.gov |
| Regulatory clearance of a rehabilitation system for individuals with upper limb loss | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,366,838 | January 15, 2021 | August 31, 2027 | KALIKI, RAHUL REDDY | reporter.nih.gov |
| Task V31: Process Development for a Panfungal Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,346,445 | January 20, 2023 | July 30, 2025 | FOUTS, TIM | reporter.nih.gov |
| Translating Pathomechanisms into Treatment for Spinal Muscular Atrophies | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,290,574 | May 5, 2021 | April 30, 2029 | SUMNER, CHARLOTTE JANE | reporter.nih.gov |
| Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,224,210 | May 25, 2023 | April 30, 2028 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,162,956 | March 25, 2022 | February 28, 2027 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Collaborative to understand impacts of early preventive interventions on suicide and overdose mortality using data harmonization methodology | NIH | National Institute of Mental Health | 2024 to 2025 | $5,154,254 | August 9, 2024 | May 31, 2028 | WILCOX, HOLLY C | reporter.nih.gov |
| Trigeminal nociceptors: Neural intersection of chronic pain and alveolar bone remodeling | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $5,140,671 | September 8, 2020 | June 30, 2028 | CHUNG, MAN-KYO | reporter.nih.gov |
| Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD | NIH | National Institute on Aging | 2021 to 2025 | $5,121,493 | September 30, 2021 | May 31, 2027 | SPIRA, ADAM PETER | reporter.nih.gov |
| Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $5,085,297 | September 5, 2022 | July 31, 2027 | URSINI, GIANLUCA | reporter.nih.gov |
| AI + Aging (a2) Coordinating Center for the NIA Artificial Intelligence and Technology Collaboratories for Aging Research (AITCs) | NIH | National Institute on Aging | 2021 to 2025 | $5,055,437 | September 30, 2021 | May 31, 2027 | LI, ROSE MARIA | reporter.nih.gov |
| Validation of Serum Neurofilament Light Chain as a Prognostic and Monitoring Biomarker in Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $5,027,415 | January 1, 2020 | December 31, 2025 | CALABRESI, PETER A | reporter.nih.gov |
| Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,016,784 | July 13, 2018 | January 31, 2030 | PAL, UTPAL | reporter.nih.gov |
| NSF PCL-Test Bed: Collaborative for the Realization of Autonomous Biomanufacturing (CRAB) Lab | NSF | Emerging Technologies Section | 2026 | $5,000,784 | August 1, 2026 | July 31, 2030 | William E Bentley | nsf.gov |
| CREST Phase I Center for Advanced Magnets and Semiconductors | NSF | Education Capacity Building & Transformation Section | 2023 | $5,000,000 | September 1, 2023 | August 31, 2028 | Abdellah Lisfi | nsf.gov |
| NSF Convergence Accelerator Track G: AVOID 5G: Automated Verification Of Internet Data-paths for 5G | NSF | Technology Accelerators Section | 2023 | $5,000,000 | September 1, 2023 | February 28, 2027 | Alexander Marder | nsf.gov |
| Global Centers Track 1: Electric Power Innovation for a Carbon-free Society (EPICS) | NSF | Office of International Science and Engineering | 2023 | $5,000,000 | November 1, 2023 | October 31, 2028 | Benjamin F Hobbs | nsf.gov |
| Global Centers Track 1: Global Nitrogen Innovation Center for Clean Energy and Environment (NICCEE) | NSF | Office of International Science and Engineering | 2023 | $5,000,000 | December 1, 2023 | November 30, 2028 | Xin Zhang | nsf.gov |
| PCL-Test Bed: The Artificial Intelligence for Materials Design Network (AIMD-NET) | NSF | Emerging Technologies Section | 2026 | $5,000,000 | August 1, 2026 | July 31, 2030 | Todd Hufnagel | nsf.gov |
| Bacteriophage-based approach for managing Shigella infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,946,719 | May 5, 2020 | April 30, 2026 | SULAKVELIDZE, ALEXANDER | reporter.nih.gov |
| Continued support for an SPF Macaca nemestrina breeding colony to provide animals to NIH funded HIV research projects | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $4,942,403 | September 21, 2006 | July 31, 2026 | HOPPER, LYDIA | reporter.nih.gov |
| Integrated Networks of Scholars in Global Health Research Training (INSIGHT) | NIH | Fogarty International Center | 2022 to 2025 | $4,936,480 | July 1, 2025 | June 30, 2027 | CHARURAT, MANHATTAN E | reporter.nih.gov |
| IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,930,056 | September 1, 2016 | December 31, 2025 | STABLIN, DON | reporter.nih.gov |
| SCIENTIFIC SUPPORT SERVICES FOR THE NATIONAL CANCER INSTITUTE, DIVISIOIN OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS) | NIH | National Cancer Institute | 2021 to 2022 | $4,921,914 | July 27, 2020 | July 26, 2023 | DAVIS, TERISA | reporter.nih.gov |
| Preclinical and early clinical development of a GABA-A a5 PAM | NIH | National Institute on Aging | 2022 to 2025 | $4,921,400 | September 1, 2022 | August 31, 2026 | PAYIE, KENNETH G | reporter.nih.gov |
| Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,856,116 | September 15, 2021 | August 31, 2026 | SEPULVEDA, PATRICIO | reporter.nih.gov |
| From Perceptions to Behaviors: A Comprehensive Approach to Examine the Impact of Public Health Communication Messaging about the Continuum of Risk for Tobacco Products | NIH | National Cancer Institute | 2024 to 2025 | $4,855,315 | August 16, 2024 | July 31, 2028 | MORAN, MEGHAN BRIDGID | reporter.nih.gov |
| CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SYSTEM (CROMS) 2.0 | NIH | National Institute on Drug Abuse | 2025 | $4,851,124 | July 1, 2025 | June 30, 2026 | reporter.nih.gov | |
| Central Coordinating Site for the Polycystic Kidney Disease (PKD) Research Core Centers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,824,202 | July 20, 2020 | August 31, 2030 | WATNICK, TERRY J | reporter.nih.gov |
| Project Safe Schools: Re-opening schools SAFELY for Native American youth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $4,799,816 | April 15, 2021 | March 31, 2024 | BARLOW, MARY ALLISON | reporter.nih.gov |
| Pathophysiology of Myocardial Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,786,349 | July 1, 1981 | June 30, 2026 | POST, WENDY S | reporter.nih.gov |
| HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $4,782,581 | August 31, 2021 | July 31, 2023 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Disability Community Engagement Partner Project | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $4,781,889 | July 1, 2021 | June 30, 2026 | FORBER-PRATT, ANJALI J | reporter.nih.gov |
| Algorithms and Software for the Assembly of Metagenomic Data | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,774,331 | March 21, 2013 | August 31, 2029 | POP, MIHAI | reporter.nih.gov |
| Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,755,161 | September 25, 2024 | December 31, 2026 | PENNINI, MEGHAN | reporter.nih.gov |
| Mechanistic studies of chromatin modification in transcription regulation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,727,113 | February 14, 2019 | April 30, 2029 | WOLBERGER, CYNTHIA | reporter.nih.gov |
| Development of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,717,265 | April 1, 2021 | March 31, 2027 | HOFFMAN, STEPHEN LEV | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,714,816 | January 1, 2025 | December 31, 2025 | ARGANI, PEDRAM | reporter.nih.gov |
| The Mobility Opportunity Voucher to Eliminate Diabetes and obesity (MOVED) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,689,372 | February 15, 2023 | January 31, 2028 | POLLACK, CRAIG EVAN | reporter.nih.gov |
| Maternal Health Data Innovation and Coordination Hub | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $4,677,230 | August 15, 2023 | January 2, 2026 | CREANGA, ANDREEA ALINA | reporter.nih.gov |
| Neurobiology of the Bronchopulmonary System | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,659,693 | March 1, 2021 | February 28, 2028 | UNDEM, BRADLEY JOEL | reporter.nih.gov |
| Maryland Polycystic Kidney Disease Research Core Center (MPKD-RCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,654,991 | August 24, 2020 | August 31, 2030 | WATNICK, TERRY J | reporter.nih.gov |
| Investigation of the Cortical Communication (CORTICOM) System | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $4,646,011 | September 15, 2020 | December 31, 2025 | CRONE, NATHAN E | reporter.nih.gov |
| Comprehensive Polygenic Risk Profiling Across Multiple Health Outcomes (CARDINAL) | NIH | National Human Genome Research Institute | 2021 to 2025 | $4,630,788 | June 8, 2021 | March 31, 2027 | ADEBAMOWO, SALLY NNEOMA | reporter.nih.gov |
| ASCEND Training Model to Increase Diversity in the Biomedical Research Workforce | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $4,615,982 | September 26, 2014 | June 30, 2025 | SHEIKHATTARI, PAYAM | reporter.nih.gov |
| SPORE in Gastrointestinal Cancers | NIH | National Cancer Institute | 2021 to 2022 | $4,598,001 | February 28, 1997 | August 31, 2024 | KLEIN, ALISON P | reporter.nih.gov |
| Completion of Non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy, NNI-362 Phase 2 POC AD trial | NIH | National Institute on Aging | 2023 to 2024 | $4,543,556 | September 1, 2023 | August 31, 2025 | KELLEHER-ANDERSSON, JUDITH A | reporter.nih.gov |
| A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $4,514,823 | April 1, 2019 | April 30, 2027 | COHEN, STEVEN M | reporter.nih.gov |
| Portable Ankle Robotics to Reverse Foot Drop After Stroke. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,504,284 | May 1, 2021 | February 28, 2025 | HENNESSIE, BRADLEY | reporter.nih.gov |
| G-RISE at UMBC | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $4,501,097 | May 1, 2022 | April 30, 2027 | BREWSTER, RACHEL MELISSA | reporter.nih.gov |
| Support for the Central Data Collection Center (CDCC) | NIH | National Cancer Institute | 2021 to 2025 | $4,460,745 | February 27, 2021 | February 26, 2025 | MATHEW, SUNITHA | reporter.nih.gov |
| SPORE in Prostate Cancer | NIH | National Cancer Institute | 2024 to 2025 | $4,454,899 | September 1, 2024 | August 31, 2029 | DENMEADE, SAMUEL R | reporter.nih.gov |
| A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $4,440,050 | September 30, 2018 | May 31, 2025 | MOHS, RICHARD CHARLES | reporter.nih.gov |
| Alcohol Policy Information System (APIS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $4,431,277 | January 1, 2023 | December 31, 2025 | SPARKS, ALICIA | reporter.nih.gov |
| Connecting FEP Research and Practice through a Learning Health System | NIH | National Institute of Mental Health | 2021 to 2023 | $4,395,151 | September 7, 2020 | August 31, 2025 | BENNETT, MELANIE E. | reporter.nih.gov |
| Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade. | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,391,293 | September 1, 2021 | June 30, 2027 | SHERMAN, SUSAN G. | reporter.nih.gov |
| Center for Immunological Interventions against Gonorrhea (CIIG) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,362,124 | August 12, 2025 | June 30, 2030 | JERSE, ANN E. | reporter.nih.gov |
| Biochemistry, Cellular and Molecular Biology Program | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $4,326,087 | July 1, 2022 | June 30, 2027 | INOUE, TAKANARI | reporter.nih.gov |
| MR-guided focused ultrasound to eradicate CNS viral reservoirs and promote neurogenesis in the HIV-infected brain | NIH | National Institute on Drug Abuse | 2021 to 2025 | $4,326,000 | June 1, 2021 | April 30, 2027 | CHANG, LINDA | reporter.nih.gov |
| Study of HIV Infection in the Etiology of Lung Disease (SHIELD) AIR: Air Pollution Impact on Respiratory Health in HIV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $4,320,983 | August 20, 2020 | July 31, 2025 | MCCORMACK, MEREDITH C | reporter.nih.gov |
| Hopkins Economics of Alzheimer's Disease & Services Center | NIH | National Institute on Aging | 2021 to 2025 | $4,317,779 | August 1, 2020 | August 31, 2027 | WOLFF, JENNIFER L. | reporter.nih.gov |
| Cellular and Molecular Biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,294,136 | July 1, 2021 | June 30, 2026 | KIM, JOHN | reporter.nih.gov |
| Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $4,294,005 | May 31, 2019 | April 30, 2025 | GEBO, KELLY A | reporter.nih.gov |
| Consumer Health Information Technology to Engage and Support ADRD Caregivers: Research Program to Address ADRD Implementation MIlestone 13.I | NIH | National Institute on Aging | 2021 to 2025 | $4,256,930 | July 15, 2021 | June 30, 2027 | WOLFF, JENNIFER L. | reporter.nih.gov |
| Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,251,563 | February 1, 2018 | February 28, 2026 | ROBB, MERLIN L | reporter.nih.gov |
| The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,204,220 | May 15, 2015 | June 30, 2030 | FLEXNER, CHARLES W. | reporter.nih.gov |
| Integrating HCV services into HIV programs for PWID in India | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,184,487 | July 8, 2019 | June 30, 2025 | MEHTA, SHRUTI H | reporter.nih.gov |
| Centralized Resource to Accurately Quantify Latent and Expressed HIV Reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,143,400 | April 13, 2020 | March 31, 2025 | LAIRD, GREGORY MICHAEL | reporter.nih.gov |
| Understanding and exploiting DNA topoisomerases in cancer biology | NIH | National Cancer Institute | 2021 to 2025 | $4,136,165 | September 1, 2021 | August 31, 2028 | BERGER, JAMES M. | reporter.nih.gov |
| DIGITAL HEALTH SOLUTIONS FOR COVID-19: DIGITAL HEALTH PASS AND SMARTER CONTACT TRACING SOLUTIONS | NIH | National Cancer Institute | 2021 | $4,135,490 | September 14, 2020 | September 13, 2021 | GOETZEL, RON | reporter.nih.gov |
| JHU TRAC: Training and Supporting the Next Generation of TB Researchers | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,102,383 | March 16, 2022 | February 28, 2027 | KARAKOUSIS, PETROS C | reporter.nih.gov |
| Validation of small vessel vascular contributions to cognitive impairment and dementia (VCID) biomarkers | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $4,093,112 | September 30, 2016 | July 31, 2027 | LU, HANZHANG | reporter.nih.gov |
Organizations by funding
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore, MD | 2,764 | $4.22 billion | 337 | $179.5 million |
| Leidos Biomedical Research, Inc. | Frederick, MD | 3 | $3.08 billion | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 811 | $1.08 billion | 5 | $1.5 million |
| Westat, Inc. | Bethesda, MD | 39 | $760 million | 2 | $1.2 million |
| University of Maryland, College Park | College Park, MD | 315 | $310.4 million | 486 | $255.2 million |
| The Emmes Company, LLC | Rockville, MD | 23 | $388.3 million | 0 | $0 |
| Technical Resources International, Inc. | Bethesda, MD | 16 | $324.1 million | 0 | $0 |
| Axle Informatics, LLC | North Bethesda, MD | 19 | $151.6 million | 0 | $0 |
| Fisher Bioservices, Inc. | Rockville, MD | 17 | $134.3 million | 0 | $0 |
| Information Management Services, Inc. | Calverton, MD | 14 | $129.7 million | 0 | $0 |
| Social and Scientific Systems, Inc. | Silver Spring, MD | 9 | $118 million | 0 | $0 |
| Henry M. Jackson FDN for the Adv Mil/med | Bethesda, MD | 80 | $108.6 million | 1 | $651,779 |
| University of Maryland Baltimore County | Baltimore, MD | 36 | $49.6 million | 102 | $53 million |
| Hugo W. Moser Res Inst Kennedy Krieger | Baltimore, MD | 64 | $88.3 million | 0 | $0 |
| Ctis, Inc. | Rockville, MD | 1 | $86.9 million | 0 | $0 |
| Digital Infuzion, Inc. | Rockville, MD | 6 | $77.3 million | 0 | $0 |
| Advanced Bioscience Laboratories, Inc. | Kensington, MD | 13 | $76.8 million | 0 | $0 |
| Precision Bioservices, Inc. | Frederick, MD | 9 | $64.2 million | 0 | $0 |
| Morgan State University | Baltimore, MD | 11 | $28.8 million | 56 | $28.7 million |
| Iq Solutions, Inc. | Rockville, MD | 9 | $46.5 million | 0 | $0 |
| Lieber Institute, Inc. | Baltimore, MD | 30 | $42.2 million | 0 | $0 |
| Sanaria, Inc. | Rockville, MD | 20 | $39.5 million | 0 | $0 |
| Friends Research Institute, Inc. | Baltimore, MD | 21 | $38.1 million | 0 | $0 |
| Center for Construction Res and Training | Silver Spring, MD | 2 | $31.9 million | 0 | $0 |
| University of Maryland Center for Environmental Sciences | Cambridge, MD | 0 | $0 | 29 | $30.8 million |
| Rise Therapeutics, LLC | Rockville, MD | 14 | $26.6 million | 0 | $0 |
| Foundation for the Nih | North Bethesda, MD | 5 | $25.2 million | 0 | $0 |
| Pacific Institute for Res and Evaluation | Beltsville, MD | 10 | $21.1 million | 0 | $0 |
| Dynport Vaccine Company, LLC | Frederick, MD | 6 | $13.9 million | 0 | $0 |
| Quality Biological, Inc. | Gaithersburg, MD | 2 | $13.9 million | 0 | $0 |
| Scanogen, Inc. | Baltimore, MD | 5 | $13.7 million | 0 | $0 |
| Antidote Therapeutics, Inc. | Sykesville, MD | 1 | $13.1 million | 0 | $0 |
| Bowie State University | Bowie, MD | 0 | $0 | 20 | $12.9 million |
| Evon Medics, LLC | Elkridge, MD | 5 | $12.5 million | 0 | $0 |
| Abvacc, Inc. | Rockville, MD | 11 | $12.2 million | 0 | $0 |
| Medstar Health Research Institute | Hyattsville, MD | 13 | $11.4 million | 0 | $0 |
| Abviro, LLC | Bethesda, MD | 2 | $11.4 million | 0 | $0 |
| Kai Research, INC | Rockville, MD | 3 | $11.3 million | 0 | $0 |
| Towson University | Towson, MD | 8 | $4.3 million | 23 | $6.9 million |
| Meso Scale Diagnostics, LLC | Rockville, MD | 6 | $10.8 million | 0 | $0 |
| Fzata, Inc. | Halethorpe, MD | 5 | $10.6 million | 0 | $0 |
| Agenebio, Inc. | Baltimore, MD | 4 | $10.2 million | 0 | $0 |
| Integrated Biotherapeutics, Inc. | Rockville, MD | 9 | $9.7 million | 0 | $0 |
| Infinite Biomedical Technologies, LLC | Baltimore, MD | 3 | $9.4 million | 0 | $0 |
| Bioqual, Inc. | Rockville, MD | 4 | $9 million | 0 | $0 |
| Creative Bio-Peptides, Inc. | Potomac, MD | 5 | $8.8 million | 0 | $0 |
| Rose Li and Associates, Inc. | Bethesda, MD | 6 | $8.3 million | 0 | $0 |
| University of Maryland Eastern Shore | Princess Anne, MD | 5 | $2.6 million | 14 | $5.4 million |
| Biomedical Research Institute | Rockville, MD | 2 | $7.9 million | 0 | $0 |
| Synergy Enterprises, Inc. | Silver Spring, MD | 3 | $7.9 million | 0 | $0 |
| Accelevir Diagnostics, LLC | Baltimore, MD | 5 | $7.8 million | 0 | $0 |
| Akyso Therapeutics, LLC | Salisbury, MD | 2 | $7.4 million | 0 | $0 |
| Cartesian Therapeutics, Inc. | Gaithersburg, MD | 5 | $7.3 million | 0 | $0 |
| Omnitec Solutions, Inc. | Bethesda, MD | 1 | $7.2 million | 0 | $0 |
| Intralytix, Inc. | Columbia, MD | 2 | $6.7 million | 0 | $0 |
| Medical Science & Computing, LLC | Rockville, MD | 3 | $6.6 million | 0 | $0 |
| Biological Mimetics, Inc. | Frederick, MD | 7 | $6.5 million | 0 | $0 |
| Palladian Partners, Inc. | Silver Spring, MD | 2 | $6.4 million | 0 | $0 |
| Autonomous Therapeutics, Inc. | Silver Spring, MD | 5 | $6.3 million | 0 | $0 |
| Macrogenics, Inc. | Rockville, MD | 1 | $6.3 million | 0 | $0 |
| Emocha Mobile Health, Inc. | Owings Mills, MD | 4 | $6.3 million | 0 | $0 |
| American College of Medical Genetics | Bethesda, MD | 1 | $6.2 million | 0 | $0 |
| Amplo Biotechnology, Inc. | Towson, MD | 2 | $6.2 million | 0 | $0 |
| Mirecule, Inc. | Gaithersburg, MD | 3 | $5.9 million | 0 | $0 |
| Emergent Product Development Gaithersbur | Gaithersburg, MD | 4 | $5.3 million | 0 | $0 |
| Sonavex, Inc. | Baltimore, MD | 3 | $5.2 million | 0 | $0 |
| Sigmovir Biosystems, Inc. | Rockville, MD | 6 | $5.1 million | 0 | $0 |
| American Physical Society | College Park, MD | 0 | $0 | 8 | $5.1 million |
| American Assn on Health and Disability | Rockville, MD | 2 | $5.1 million | 0 | $0 |
| Neuronascent, Inc. | Clarksville, MD | 2 | $4.8 million | 0 | $0 |
| Loyola University Maryland, Inc. | Baltimore, MD | 0 | $0 | 6 | $4.6 million |
| Vectech, LLC | Baltimore, MD | 3 | $3.5 million | 1 | $999,479 |
| Nextstep Robotics, LLC | Baltimore, MD | 1 | $4.5 million | 0 | $0 |
| Maryland Treatment Centers, Inc. | Baltimore, MD | 3 | $4.3 million | 0 | $0 |
| Glycomantra, Inc. | Halethorpe, MD | 2 | $4.3 million | 0 | $0 |
| American Association of Physics Teachers | College Park, MD | 0 | $0 | 3 | $4.3 million |
| Child Trends Inc | Rockville, MD | 0 | $0 | 4 | $4.2 million |
| Aromha, Inc. | Potomac, MD | 2 | $4.2 million | 0 | $0 |
| Medigen, Inc. | Frederick, MD | 3 | $4.2 million | 0 | $0 |
| Federation of Amer Soc for Exper Biology | Rockville, MD | 110 | $3.5 million | 13 | $690,719 |
| Vasoptic Medical, Inc. | Baltimore, MD | 4 | $4.2 million | 0 | $0 |
| International Business Machines Corp | Bethesda, MD | 1 | $4.1 million | 0 | $0 |
| Sonoval LLC | Gaithersburg, MD | 2 | $4 million | 0 | $0 |
| Cog Analytics, LLC | Potomac, MD | 3 | $4 million | 0 | $0 |
| Total Child Health, Inc. | Baltimore, MD | 3 | $3.8 million | 0 | $0 |
| Montgomery College | Rockville, MD | 0 | $0 | 5 | $3.8 million |
| Primetime Life Sciences, LLC | Germantown, MD | 2 | $3.8 million | 0 | $0 |
| Verachem, LLC | Germantown, MD | 2 | $3.8 million | 0 | $0 |
| Oncosting LLC | Baltimore, MD | 2 | $3.5 million | 1 | $256,000 |
| Tengen Biomedical Co. | Bethesda, MD | 3 | $3.6 million | 0 | $0 |
| Appili Therapeutics USA Inc. | Frederick, MD | 1 | $3.6 million | 0 | $0 |
| Engineering for US All, Inc. | College Park, MD | 0 | $0 | 1 | $3.6 million |
| American Gastroenterological Assn/inst | Bethesda, MD | 3 | $3.6 million | 0 | $0 |
| Zalgen Labs, LLC | Germantown, MD | 1 | $3.6 million | 0 | $0 |
| Glycot Therapeutics, LLC | Ellicott City, MD | 3 | $3.5 million | 0 | $0 |
| Kalocyte, Inc. | Baltimore, MD | 2 | $3.5 million | 0 | $0 |
| Radiopharmaceutical Imaging and Dosimetry, LLC | Baltimore, MD | 3 | $3.4 million | 0 | $0 |
| CDM Group, Inc. | Bethesda, MD | 2 | $3.3 million | 0 | $0 |
| Gryphon Scientific, LLC | Takoma Park, MD | 2 | $3.3 million | 0 | $0 |
| Insilica, LLC | Bethesda, MD | 4 | $1.9 million | 1 | $1.5 million |
| Akonni Biosystems, Inc. | Frederick, MD | 2 | $3.3 million | 0 | $0 |
| Clear Guide Medical, Inc. | Baltimore, MD | 3 | $3.3 million | 0 | $0 |
| Exbaq LLC | Bethesda, MD | 2 | $3.3 million | 0 | $0 |
| Maxim Biomedical, Inc. | Rockville, MD | 1 | $3.2 million | 0 | $0 |
| Simmersion, LLC. | Columbia, MD | 2 | $3.1 million | 0 | $0 |
| Capsulomics, LLC | Baltimore, MD | 3 | $3.1 million | 0 | $0 |
| Pediametrix Inc. | Rockville, MD | 2 | $3.1 million | 0 | $0 |
| Isoprene Pharmaceuticals, Inc. | Baltimore, MD | 2 | $3 million | 0 | $0 |
| Linshom Medical INC | Ellicott City, MD | 2 | $3 million | 0 | $0 |
| Nelson Scientific Labs LLC | Potomac, MD | 2 | $2.9 million | 0 | $0 |
| Coram Technologies, Inc. | Pikesville, MD | 3 | $2.8 million | 0 | $0 |
| Up Therapeutics, Inc. | Frederick, MD | 3 | $2.8 million | 0 | $0 |
| Hbvtech | Germantown, MD | 5 | $2.7 million | 0 | $0 |
| Aavogen, Inc. | Rockville, MD | 4 | $2.6 million | 0 | $0 |
| St Mary's College of Maryland | Saint Marys City, MD | 0 | $0 | 7 | $2.6 million |
| Mountainpass Technology, LLC | Chevy Chase, MD | 4 | $2.5 million | 0 | $0 |
| Sentimetrix, Inc. | Bethesda, MD | 2 | $2.5 million | 0 | $0 |
| Pocket Naloxone Corp. | Bethesda, MD | 1 | $2.4 million | 0 | $0 |
| Rehabtek, LLC | Linthicum Heights, MD | 1 | $2.3 million | 0 | $0 |
| Cogentis Therapeutics, Inc. | Baltimore, MD | 1 | $2.2 million | 0 | $0 |
| Zeteo Tech, Inc. | Sykesville, MD | 2 | $2.2 million | 0 | $0 |
| Prompt Diagnostics, Inc. | Baltimore, MD | 2 | $558,558 | 2 | $1.5 million |
| Pericor, LLC | Bethesda, MD | 2 | $2.1 million | 0 | $0 |
| Nostopharma, LLC | Potomac, MD | 2 | $770,982 | 2 | $1.3 million |
| Asell, LLC | Owings Mills, MD | 1 | $2 million | 0 | $0 |
| Oncoc4, Inc. | Rockville, MD | 1 | $2 million | 0 | $0 |
| Avoneaux Medical Institute, LLC | Easton, MD | 1 | $2 million | 0 | $0 |
| Mimetas Us, Inc. | Gaithersburg, MD | 2 | $2 million | 0 | $0 |
| Pearl Diagnostics, Inc. | Baltimore, MD | 2 | $2 million | 0 | $0 |
| Pza Innovation LLC | Towson, MD | 1 | $1.7 million | 1 | $270,509 |
| Sigt, LLC | Columbia, MD | 2 | $1.9 million | 0 | $0 |
| Salisbury University | Salisbury, MD | 0 | $0 | 5 | $1.9 million |
| American Society for Biochemistry and Molecular Biology | Rockville, MD | 1 | $1.2 million | 2 | $629,626 |
| Kubanda Cryotherapy, Inc. | Baltimore, MD | 2 | $1.8 million | 0 | $0 |
| Tetracore, Inc. | Rockville, MD | 2 | $1.8 million | 0 | $0 |
| American Society for Cell Biology | Rockville, MD | 2 | $1.8 million | 0 | $0 |
| Silcsbio, LLC | Baltimore, MD | 1 | $1.8 million | 0 | $0 |
| Sonnest, Inc. | Baltimore, MD | 1 | $1.7 million | 0 | $0 |
| Liatris Inc. | Rockville, MD | 0 | $0 | 1 | $1.7 million |
| D'vinci Interactive, Inc. | Hagerstown, MD | 1 | $1.7 million | 0 | $0 |
| Reveragen Biopharma, Inc. | Rockville, MD | 1 | $1.7 million | 0 | $0 |
| Simmbion LLC | Baltimore, MD | 0 | $0 | 2 | $1.7 million |
| Digital Harbor Foundation | Baltimore, MD | 0 | $0 | 1 | $1.6 million |
| Natsar Pharmaceuticals, Inc. | Ellicott City, MD | 1 | $1.6 million | 0 | $0 |
| LCG Systems, LLC | Rockville, MD | 2 | $1.6 million | 0 | $0 |
| Johnson, Bassin and Shaw, Inc. | North Bethesda, MD | 1 | $1.6 million | 0 | $0 |
| Astek Diagnostics LLC | Elkridge, MD | 0 | $0 | 3 | $1.5 million |
| Immunoblue, LLC | Bethesda, MD | 2 | $1.5 million | 0 | $0 |
| MS Technologies Corporation | Rockville, MD | 2 | $1.5 million | 0 | $0 |
| Novus Vision LLC | Baltimore, MD | 1 | $1.5 million | 0 | $0 |
| Alcamena Stem Cell Therapeutics, LLC | Baltimore, MD | 1 | $1.5 million | 0 | $0 |
| Aidar Health, INC | Pikesville, MD | 0 | $0 | 1 | $1.5 million |
| Taumat LLC | Silver Spring, MD | 0 | $0 | 2 | $1.5 million |
| Lasarrus Clinic and Research Center, Inc. | Baltimore, MD | 1 | $1.5 million | 0 | $0 |
| DFH Pharma, Inc. | Gaithersburg, MD | 2 | $1.4 million | 0 | $0 |
| Prevep, Inc. | Bethesda, MD | 2 | $1.4 million | 0 | $0 |
| Rithim Biologics, Inc. | Woodbine, MD | 1 | $1.4 million | 0 | $0 |
| Computchem LLC | Baltimore, MD | 1 | $1.4 million | 0 | $0 |
| Mount ST. Mary's University | Emmitsburg, MD | 2 | $714,371 | 1 | $616,215 |
| Mesa Science Associates, Inc. | Frederick, MD | 2 | $1.3 million | 0 | $0 |
| A and G Pharmaceutical, Inc. | Columbia, MD | 3 | $1.3 million | 0 | $0 |
| Community College of Baltimore County, Essex | Dundalk, MD | 0 | $0 | 1 | $1.3 million |
| Novel Microdevices, LLC | Baltimore, MD | 2 | $1.3 million | 0 | $0 |
| Spirit Fit & Health INC | Kensington, MD | 1 | $1.2 million | 0 | $0 |
| Cogthera, LLC | Brookeville, MD | 2 | $1.2 million | 0 | $0 |
| Coppin State University | Baltimore, MD | 0 | $0 | 5 | $1.2 million |
| Unither Virology, LLC | Gaithersburg, MD | 1 | $1.2 million | 0 | $0 |
| Lumo Imaging LLC | Potomac, MD | 0 | $0 | 1 | $1.2 million |
| Pneumonix Medical Inc. | Baltimore, MD | 0 | $0 | 1 | $1.2 million |
| Weinberg Medical Physics, LLC | North Bethesda, MD | 2 | $1.2 million | 0 | $0 |
| Sonavi Labs, Inc. | Baltimore, MD | 1 | $1.1 million | 0 | $0 |
| Rembac Environmental, LLC | Ellicott City, MD | 1 | $1.1 million | 0 | $0 |
| From Prison Cells to PHD, Inc. | Baltimore, MD | 1 | $1.1 million | 0 | $0 |
| Society For Developmental Biol | Rockville, MD | 4 | $913,522 | 3 | $200,000 |
| Chesapeake Genomic Systems LLC | Halethorpe, MD | 4 | $1.1 million | 0 | $0 |
| Hood College | Frederick, MD | 0 | $0 | 2 | $1.1 million |
| United States Naval Academy | Annapolis, MD | 0 | $0 | 7 | $1.1 million |
| Tanzen Medical, Inc. | Severna Park, MD | 2 | $1 million | 0 | $0 |
| Walter Reed Army Institute of Research | Silver Spring, MD | 1 | $1 million | 0 | $0 |
| Eyedea Medical, INC | Baltimore, MD | 0 | $0 | 1 | $1 million |
| Kinarx, LLC | Rockville, MD | 1 | $999,998 | 0 | $0 |
| Silvec Biologics, Inc. | Gaithersburg, MD | 0 | $0 | 1 | $994,939 |
| Mpod, Inc. | Laurel, MD | 1 | $992,609 | 0 | $0 |
| Softhread, Inc. | Catonsville, MD | 0 | $0 | 1 | $984,905 |
| Cooltech LLC | Baltimore, MD | 1 | $983,042 | 0 | $0 |
| Oncospace, Inc. | Baltimore, MD | 2 | $920,740 | 0 | $0 |
| Key Technologies, Inc. | Baltimore, MD | 1 | $915,105 | 0 | $0 |
| Ripple Effect Communications, Inc. | Rockville, MD | 3 | $914,193 | 0 | $0 |
| Vitruvian Bio, LLC | Ellicott City, MD | 3 | $899,967 | 0 | $0 |
| Cardiosolv Ablation Technologies, Inc. | Baltimore, MD | 1 | $870,222 | 0 | $0 |
| Care Progress, LLC | Bethesda, MD | 2 | $800,569 | 0 | $0 |
| Coaptech, LLC | Baltimore, MD | 1 | $774,058 | 0 | $0 |
| Howard Community College | Columbia, MD | 0 | $0 | 1 | $767,503 |
| Bowie State University | Bowie, MD | 1 | $765,600 | 0 | $0 |
| Perceptive Navigation, LLC | Baltimore, MD | 2 | $760,042 | 0 | $0 |
| Netrias, LLC | Annapolis, MD | 1 | $742,569 | 0 | $0 |
| Software Consultants, Inc. | Lanham, MD | 1 | $727,620 | 0 | $0 |
| Seetrue Technology, LLC | Rockville, MD | 2 | $699,890 | 0 | $0 |
| Rezigene, LLC | Baltimore, MD | 1 | $694,318 | 0 | $0 |
| National Medical Association | Silver Spring, MD | 3 | $676,000 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 207 | $95,326,325 |
| 2025 | 2,132 | $2,142,007,555 | 321 | $151,761,084 |
| 2024 | 2,350 | $2,434,859,710 | 348 | $123,326,695 |
| 2023 | 2,318 | $2,746,202,788 | 362 | $152,791,383 |
| 2022 | 2,359 | $2,407,362,751 | 284 | $115,902,493 |
| 2021 | 2,371 | $2,396,755,440 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.